Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Degott

Showing results (301-310 of 320) with videos related to

Pageof 32
Sort By:
Journal of Hepatology|August 29, 1998
Predictors of sustained response to alpha interferon therapy in chronic hepatitis CM Martinot-Peignoux, N Boyer, M Pouteau, et al.
Gastroenterologie Clinique Et Biologique|July 23, 1999
[Hepatic brucelloma: 2 cases and a review of the literature]C Halimi, N Bringard, N Boyer, et al.
Gastroenterologie Clinique Et Biologique|October 1, 1983
[Nodular regenerative hyperplasia of the liver. Study of 15 cases and review of the literature]J P Capron, C Degott, J Bernuau, et al.
Gastroenterology|February 1, 1995
Immunostaining for membrane attack complex of complement is related to cell necrosis in fulminant and acute hepatitisB N Pham, J F Mosnier, F Durand, et al.
Gastroenterology|July 1, 1990
Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosisK Lassoued, R Brenard, F Degos, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1983
[Acute hepatitis caused by isaxonine phosphate (Nerfactor)]F Baud, J Bernuau, N Benmami, et al.
Annals of Internal Medicine|February 12, 1998
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapyP Marcellin, N Boyer, A Gervais, et al.
Hepatology (Baltimore, Md.)|October 27, 2001
Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNAM Martinot-Peignoux, N Boyer, D Cazals-Hatem, et al.
Transplantation|June 15, 1995
alpha-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimenA C Gadano, J F Mosnier, F Durand, et al.
The New England Journal of Medicine|February 15, 2001
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile ductP Hammel, A Couvelard, D O'Toole, et al.
Pageof 32

Showing results (301-310 of 320) with videos related to

Sort By:
Pageof 32
Journal of Hepatology|August 29, 1998
Predictors of sustained response to alpha interferon therapy in chronic hepatitis CM Martinot-Peignoux, N Boyer, M Pouteau, et al.
Gastroenterologie Clinique Et Biologique|July 23, 1999
[Hepatic brucelloma: 2 cases and a review of the literature]C Halimi, N Bringard, N Boyer, et al.
Gastroenterologie Clinique Et Biologique|October 1, 1983
[Nodular regenerative hyperplasia of the liver. Study of 15 cases and review of the literature]J P Capron, C Degott, J Bernuau, et al.
Gastroenterology|February 1, 1995
Immunostaining for membrane attack complex of complement is related to cell necrosis in fulminant and acute hepatitisB N Pham, J F Mosnier, F Durand, et al.
Gastroenterology|July 1, 1990
Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosisK Lassoued, R Brenard, F Degos, et al.
Gastroenterologie Clinique Et Biologique|April 1, 1983
[Acute hepatitis caused by isaxonine phosphate (Nerfactor)]F Baud, J Bernuau, N Benmami, et al.
Annals of Internal Medicine|February 12, 1998
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapyP Marcellin, N Boyer, A Gervais, et al.
Hepatology (Baltimore, Md.)|October 27, 2001
Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNAM Martinot-Peignoux, N Boyer, D Cazals-Hatem, et al.
Transplantation|June 15, 1995
alpha-Interferon-induced rejection of a hepatitis C virus-infected liver allograft tolerated with a low dosage immunosuppressive regimenA C Gadano, J F Mosnier, F Durand, et al.
The New England Journal of Medicine|February 15, 2001
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile ductP Hammel, A Couvelard, D O'Toole, et al.
Pageof 32